Watchlist Price Alert

RVL Pharmaceuticals (OSMT)

NASDAQ: OSMT · Real-Time Price · USD

1.11

-0.02 (-1.77%)

At close: Jan 19, 2022, 5:00 AM

RVL Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	44.54M	40.44M	114.05M	95.86M	70.83M	34.74M	19.56M
Short-Term Investments	n/a	3.06M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	102.51M	2.25M	751.93K	942.42K	2.45M
Receivables	3.03M	2.13M	3.15M	43.91M	56.42M	37.64M	45.32M
Inventory	784K	838K	1.83M	21.3M	24.38M	16.95M	19.84M
Other Current Assets	8.62M	15.96M	12.59M	11.55M	20.72M	25.81M	9.49M
Total Current Assets	56.98M	59.38M	173.15M	172.63M	172.36M	115.14M	94.21M
Property-Plant & Equipment	1.79M	2.23M	4.34M	35.22M	31.26M	31.41M	27.73M
Goodwill & Intangibles	69.75M	83.06M	90.94M	254.84M	591.24M	738.2M	854.11M
Total Long-Term Assets	71.53M	85.29M	197.79M	292.31M	623.26M	770.56M	884.29M
Total Assets	128.51M	144.67M	370.95M	463.25M	795.62M	885.7M	978.5M
Account Payables	2.41M	3.78M	3.13M	8.49M	24.87M	36.07M	34.98M
Deferred Revenue	1.92M	67K	28K	n/a	101.35K	228.12K	201.36K
Short-Term Debt	1.88M	3.25M	1.22M	2.19M	1.89M	6.68M	5.28M
Other Current Liabilities	13.52M	13.01M	51.41M	65.25M	87.14M	81.7M	77.37M
Total Current Liabilities	19.72M	20.11M	55.78M	75.94M	114M	124.68M	117.83M
Long-Term Debt	55.61M	44.39M	220.97M	271.11M	266.94M	314.01M	323.74M
Other Long-Term Liabilities	2.08M	3.44M	344K	n/a	1.8M	2.38M	4.16M
Total Long-Term Liabilities	57.69M	47.83M	221.31M	272.61M	297.78M	341.75M	395.46M
Total Liabilities	77.42M	67.94M	277.09M	348.55M	411.78M	466.43M	513.3M
Total Debt	57.49M	47.65M	221.62M	273.3M	268.83M	320.69M	329.02M
Common Stock	992K	833K	625K	518K	525.19K	n/a	n/a
Retained Earnings	-569.22M	-517.53M	-452.61M	-373.02M	-102.12M	n/a	n/a
Comprehensive Income	n/a	1.7M	-2.23M	-2.23M	-1.85M	-633.15K	274.78K
Shareholders Equity	51.09M	76.73M	93.86M	114.71M	383.85M	419.27M	465.21M
Total Investments	n/a	3.06M	n/a	n/a	n/a	n/a	n/a